Do women benefit more from systemic thrombolysis in acute ischemic stroke? A Serbian experience with thrombolysis in ischemic stroke (SETIS) study

Clinical Neurology and Neurosurgery

Volumn 111, Issue 9, 2009, Pages 729-732

  Jovanovic D R ^a   Beslac Bumbasirevic Lj ^a   Budimkic M ^a   Pekmezovic T ^b   Zivkovic M ^c   Kostic V S ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c Clinical Centre Nis   (Serbia)

Author keywords

Acute; Outcome; Stroke; Thrombolysis; Women

Indexed keywords

ALTEPLASE;

ADULT; ARTICLE; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; SERBIA; SEX DIFFERENCE;

ACUTE DISEASE; ADULT; AGED; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PROSPECTIVE STUDIES; RISK FACTORS; SERBIA; SEX CHARACTERISTICS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70349600311     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2009.06.014     Document Type: Article

References (18)

1. Reeves M.J., Bushnell C.D., Howard G., Gargano J.W., Duncan P.W., Lynch G., et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol 7 (2008) 915-926
2. Niewada M., Kobayashi A., Sandercock P.A., Kaminski B., and Czlonkowska A. Influence of gender on baseline features and clinical outcomes among 17 370 patients with confirmed ischemic stroke in the international stroke trial. Neuroepidemiology 24 (2005) 123-128
3. Ridker P.M., Cook N.R., Lee I.-M., Gordon D., Gaziano J.M., Manson J.E., et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 352 (2005) 1293-1304
4. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing physicians' health study. N Engl J Med 1989; 321:129-135.
5. Kent D.M., Price L.L., Ringleb P., Hill M.D., and Selker H.P. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke 36 (2005) 62-65
6. Savitz S.I., Schlaug G., Caplan L., and Selim M. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke 36 (2005) 1447-1451
7. Saposnik G., Di Legge S., Webster F., and Hachinski V. Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology 65 (2005) 1169-1174
8. Elkind M.S., Prabhakaran S., Pittman J., Koroshetz W., Jacoby M., Johnston K.C., et al. Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke. Neurology 68 (2007) 842-848
9. Barber P.A., Demchuk A.M., Zhang J., and Buchan A.M. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy ASPECTS Study Group. Alberta Stroke Pragramme Early CT Score. Lancet 355 (2000) 1670-1674
10. Bamford J., Sandercock P., Dennis M., Burn J., and Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337 (1991) 1521-1526
11. Adams H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 24 (1993) 35-41
12. Larrue V., von Kummer R.R., Muller A., and Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 32 (2001) 438-441
13. Kent D.M., Buchan A.M., and Hill M.D. The gender effect in stroke thrombolysis. Of CASES, controls and treatment-effect modification. Neurology 71 (2008) 1080-1083
14. Hill M.D., Kent D.M., Hinchey J., Rowley H., Buchan A.M., Wechsler L.R., et al. Sex-based differences in the effect of intra-arterial treatment of stroke. Analysis of the PROACT-2 study. Stroke 37 (2006) 2322-2325
15. Fernandez-Cadenas I., Alvarez-Sabin J., Ribo M., Rubiera M., Mendioroz M., Molina C.A., et al. Influence of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 gene polymorphisms on tissue-type plasminogen activator-induced recanalization in ischemic stroke patients. J Thromb Haemost 5 9 (2007 Sep) 1862-1868
16. Kain K., Carter A.M., Bamford J.M., Grant P.J., and Catto A.J. Gender differences in coagulation and fibrinolysis in white subjects with acute ischemic stroke. J Thromb Haemost 1 (2003) 390-392
17. Ribo M., Montaner J., Molina C.A., Arenillas J.F., Santamarina E., and Alvarez-Sabin J. Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator. J Thromb Haemost 91 (2004) 1146-1151
18. Roquer J., Campello A.R., and Gomis M. Sex differences in first-ever acute stroke. Stroke 34 (2003) 1581-1585